Primary |
Epilepsy |
36.4% |
Pain |
18.3% |
Convulsion |
5.1% |
Partial Seizures |
5.1% |
Cancer Pain |
4.4% |
Insomnia |
4.1% |
Neuralgia |
3.8% |
Post Herpetic Neuralgia |
3.1% |
Depression |
2.5% |
Fibromyalgia |
2.1% |
Pain In Extremity |
2.1% |
Temporal Lobe Epilepsy |
2.1% |
Hypoaesthesia |
1.8% |
Hypertension |
1.6% |
Analgesic Therapy |
1.5% |
Trigeminal Neuralgia |
1.5% |
Complex Partial Seizures |
1.2% |
Constipation |
1.2% |
Diabetes Mellitus |
1.0% |
Intractable Epilepsy |
1.0% |
|
Somnolence |
25.0% |
Epilepsy |
8.9% |
Weight Increased |
7.8% |
Renal Impairment |
5.2% |
Status Epilepticus |
5.2% |
Urine Output Decreased |
5.2% |
Convulsion |
4.7% |
Depressed Level Of Consciousness |
4.2% |
White Blood Cell Count Decreased |
3.6% |
Pain |
3.1% |
Urinary Incontinence |
3.1% |
Visual Acuity Reduced |
3.1% |
Blood Creatine Phosphokinase Increased |
2.6% |
Death |
2.6% |
Drug Eruption |
2.6% |
Gamma-glutamyltransferase Increased |
2.6% |
Hyperkalaemia |
2.6% |
Interstitial Lung Disease |
2.6% |
Pyrexia |
2.6% |
Withdrawal Syndrome |
2.6% |
|
Secondary |
Pain |
34.4% |
Epilepsy |
11.6% |
Hyperlipidaemia |
5.0% |
Insomnia |
4.5% |
Partial Seizures |
4.5% |
Headache |
4.3% |
Diarrhoea |
3.5% |
Drug Use For Unknown Indication |
3.5% |
Hernia Pain |
3.3% |
Neuralgia |
3.3% |
Abdominal Hernia |
3.0% |
Hypertension |
3.0% |
Ulcer |
3.0% |
Constipation |
2.8% |
Back Pain |
2.0% |
Post Herpetic Neuralgia |
2.0% |
Encephalitis |
1.8% |
Benign Prostatic Hyperplasia |
1.5% |
Depression |
1.5% |
Herpes Zoster |
1.5% |
|
Somnolence |
27.2% |
Neoplasm Progression |
8.6% |
White Blood Cell Count Increased |
7.4% |
Convulsion |
6.2% |
Overdose |
6.2% |
Renal Impairment |
4.9% |
Vision Blurred |
4.9% |
Iron Deficiency Anaemia |
3.7% |
Pruritus |
3.7% |
Cardiac Failure |
2.5% |
Epilepsy |
2.5% |
Postrenal Failure |
2.5% |
Stomatitis Necrotising |
2.5% |
Tachycardia |
2.5% |
Thrombocytopenia |
2.5% |
Tinnitus |
2.5% |
Toxicity To Various Agents |
2.5% |
Urine Output Decreased |
2.5% |
Weight Decreased |
2.5% |
Withdrawal Syndrome |
2.5% |
|
Concomitant |
Pain |
17.3% |
Prophylaxis |
16.0% |
Cancer Pain |
8.7% |
Epilepsy |
8.0% |
Drug Use For Unknown Indication |
5.2% |
Constipation |
5.0% |
Analgesic Therapy |
4.9% |
Multiple Myeloma |
4.6% |
Product Used For Unknown Indication |
3.3% |
Lennox-gastaut Syndrome |
3.2% |
Hypertension |
3.1% |
Complex Partial Seizures |
2.9% |
Simple Partial Seizures |
2.9% |
Plasma Cell Myeloma |
2.7% |
Delirium |
2.6% |
Hepatic Neoplasm Malignant |
2.1% |
Insomnia |
1.9% |
Partial Seizures With Secondary Generalisation |
1.9% |
Pneumonia Aspiration |
1.9% |
Nausea |
1.8% |
|
Wrong Technique In Drug Usage Process |
13.2% |
Tumour Lysis Syndrome |
11.2% |
Status Epilepticus |
10.5% |
Epilepsy |
6.6% |
Thrombocytopenia |
5.9% |
Interstitial Lung Disease |
5.3% |
White Blood Cell Count Decreased |
5.3% |
Palmar-plantar Erythrodysaesthesia Syndrome |
3.9% |
Platelet Count Decreased |
3.9% |
Pyrexia |
3.9% |
Somnolence |
3.9% |
Pancreatitis Acute |
3.3% |
Pneumonia |
3.3% |
Rash |
3.3% |
Vomiting |
3.3% |
Altered State Of Consciousness |
2.6% |
Convulsion |
2.6% |
Drug Prescribing Error |
2.6% |
Liver Disorder |
2.6% |
Pain |
2.6% |
|
Interacting |
Fibromyalgia |
27.8% |
Prophylaxis |
16.7% |
Atrial Fibrillation |
11.1% |
Cancer Pain |
11.1% |
Hypertension |
11.1% |
Multiple Myeloma |
11.1% |
Pain |
11.1% |
|
Somnolence |
50.0% |
Rash |
25.0% |
Thrombocytopenia |
25.0% |
|